首页 / 院系成果 / 成果详情页

Mitoxantrone hydrochloride liposome, gemcitabine, vinorelbine with or without anti-CD20 antibody (GVM±CD20) in patients with relapsed or refractory aggressive non-Hodgkin''s lymphoma: A prospective, multicenter, Phase II study 会议论文

编号：

0F52BEE7591BF36CD58F5634764259D0
作者：

Liu, Wei^[1] Huang, Chen^[2] Yan, Xiaojing^[3] Huang, Yunhong^[4] Bai, Ou^[5] Jia, Yongqian^[6] Jing, Hongmei^[7] Wang, Xiaobo^[8] Zhou, Zeping Li, Fei^[10] Li, Zhenling^[11] Zhong, Mingxing^[12] Liu, Aichun^[13] Sun, Wanling^[14] Yang, Haiyan^[15] He, Jianxia^[16] Wang, Jigang^[17] Liao, Aijun^[18] Liu, Haisheng^[2] Qiu, Lugui^[1]
语种：

英文
会议名称：

BLOOD
收录：
推荐引用方式
GB/T 7714：

Liu Wei,Huang Chen,Yan Xiaojing, et al. Mitoxantrone hydrochloride liposome, gemcitabine, vinorelbine with or without anti-CD20 antibody (GVM±CD20) in patients with relapsed or refractory aggressive non-Hodgkin''s lymphoma: A prospective, multicenter, Phase II study [J].BLOOD,2025,146:1919-1920.
APA：

Liu Wei,Huang Chen,Yan Xiaojing,Huang Yunhong,&Qiu Lugui.(2025).Mitoxantrone hydrochloride liposome, gemcitabine, vinorelbine with or without anti-CD20 antibody (GVM±CD20) in patients with relapsed or refractory aggressive non-Hodgkin''s lymphoma: A prospective, multicenter, Phase II study .BLOOD,146:1919-1920.
MLA：

Liu Wei, et al. "Mitoxantrone hydrochloride liposome, gemcitabine, vinorelbine with or without anti-CD20 antibody (GVM±CD20) in patients with relapsed or refractory aggressive non-Hodgkin''s lymphoma: A prospective, multicenter, Phase II study" .BLOOD 146(2025):1919-1920.
入库时间：

2026/1/21 8:16:22
更新时间：

2026/1/21 8:16:22

浏览次数：20  下载次数：0

浏览次数：20

下载次数：0

打印次数：0